TokenPost·
POMDOCTOR Meets Nasdaq’s $1 Bid Rule as Two Listing Deficiencies Remain
POMDOCTOR said Nasdaq canceled a Nov. 12 hearing; the remaining market-value requirements have deadlines of April 26, 2027.
More news
- TokenPostBiglari Holdings Posts Q3 GAAP EPS of -$3.91 as Revenue Rises 12.4%
- TokenPostOUTFRONT Expects About 25% AFFO Growth in 2026 After Q3 Revenue Gains
- TokenPostNI Holdings Posts $0.27 in Basic Q3 Earnings Per Share After a Loss
- TokenPostSafehold Valuation Loss Pushes Star Holdings to $3.74 Q3 Loss Per Share
- TokenPostBitGo Flags Costs From Daily Securities-Lending Settlement Fails
- TokenPostAnthropic Tests Find Claude Memory Gains on Some Document Tasks